Title : Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.

Pub. Date : 2017 Jun

PMID : 28415048






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-kappaB pathway. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
2 We found that A549/CDDP (resistant to CDDP) cells not only acquired epithelial-mesenchymal transition (EMT) phenotype, but also showed increased NF-kappaB activity compared with A549 cells (sensitive to CDDP). Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
3 We found that A549/CDDP (resistant to CDDP) cells not only acquired epithelial-mesenchymal transition (EMT) phenotype, but also showed increased NF-kappaB activity compared with A549 cells (sensitive to CDDP). Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
4 We found that A549/CDDP (resistant to CDDP) cells not only acquired epithelial-mesenchymal transition (EMT) phenotype, but also showed increased NF-kappaB activity compared with A549 cells (sensitive to CDDP). Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
5 Our study further demonstrated that PI3K/Akt/NF-kappaB pathway controlled CDDP resistance via EMT and NF-kappaB-mediated apoptosis. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens
6 Our study further demonstrated that PI3K/Akt/NF-kappaB pathway controlled CDDP resistance via EMT and NF-kappaB-mediated apoptosis. Cisplatin nuclear factor kappa B subunit 1 Homo sapiens